PTPRC and Miyoshi myopathy: Using siRNA silencing techniques, we successfully and specifically abrogated CD45 expression in these MM cell lines (Figure 3C) and showed that CD45 siRNA-transfected (but not control siRNA-transfected) MDN and XG2 cells lost their ability to migrate in response to CXCL12 (Figure 3D).